Ischemic Stroke Due to Compression of a Wandering Internal Carotid Artery by the Hyoid Bone
This case report describes a 75-year-old man who presented with sudden-onset right hemiplegia.
This case report describes a 75-year-old man who presented with sudden-onset right hemiplegia.
This JAMA Insights explores effective communication strategies for clinicians who do not specialize in treating obesity in how to introduce conversations about weight loss with their patients and offer them support and treatment.
This toolkit will help you identify ways your practice can promote racial and health equity, using data to better understand your patient population. The toolkit describes how to develop clear, attainable health equity goals and create a plan for improvement…
Importance The advanced ambulatory heart failure (HF) population comprises patients who have progressed beyond the pillars of recommended stage C HF therapies but can still find meaningful life-years ahead. Although these patients are commonly encountered in practice, national databases selectively capture…
A man in his 50s with hepatitis C presented with an enlarging painless nodule on the right index finger. What is your diagnosis?
This JAMA Network Insight describes the use of mendelian randomization, including key assumptions that must be met, in dermatology research.
This JAMA Clinical Guidelines Synopsis summarizes the American Thoracic Society’s 2023 guidelines on pulmonary rehabilitation for adults with chronic respiratory disease.
Importance Achieving remission is the first step toward a cure in treating aggressive B-cell lymphomas. Radiographic imaging, such as fluorodeoxyglucose–positron emission tomography/computed tomography scans are the current standard to define remission at the end of therapy but lack specificity for lymphoma…
A previously healthy 67-year-old man was referred to the otolaryngology department due to a progressively worsening sore throat associated with unintentional weight loss and night sweats. What is your diagnosis?
This JAMA Insights discusses the recent FDA approval of obecabtagene autoleucel for adults with relapsed or refractory B-cell acute lymphoblastic leukemia and provides regulatory considerations.
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org